Tech Company Financing Transactions
Plexision Funding Round
Plexision closed a $365 thousand investment round on 7/25/2025. Investors included Richard King Mellon Foundation.
Transaction Overview
Company Name
Announced On
7/25/2025
Transaction Type
Venture Equity
Amount
$365,000
Round
Undisclosed
Investors
Proceeds Purpose
The funds will be used to accelerate the integration of artificial intelligence (AI) and machine learning (ML) capabilities across its suite of cell-based blood tests, improving predictive accuracy for complex transplant outcomes.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4424 Penn Ave. 202
Pittsburgh, PA 15224
USA
Pittsburgh, PA 15224
USA
Phone
Website
Email Address
Overview
Plexision develops cellular biomarkers for personalized diagnostics and drug development in infectious diseases, solid organ transplantation, as well as immuno-oncology. These tests are based on patented technology that measures antigen-specific white blood cells. Testing services for patients, researchers, and drug developers are provided by Plexision's CLIA-certified, GMP-compliant central laboratory in Pittsburgh, Pennsylvania. Plexision's team consists of highly-trained technologists, cytometrists, clinicians, scientists, bioentrepreneurs, and bioinformaticians.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rakesh Sindhi
VP - Operations
Ashok Reddy
Browse more venture capital transactions:
Prev: 7/25/2025: Bloom Labs venture capital transaction
Next: 7/25/2025: Spaceflux venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs